A Single-Center Pilot Study to Assess Macular Function
NCT01204541 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2012-02-14
Summary
This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.
Conditions
- Macular Degeneration
Sponsors & Collaborators
-
ORA, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2010-10-31
- Completion
- 2010-10-31
Countries
- United States
Study Locations
More Related Trials
-
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
NCT01255462 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration
NCT02022501 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
NCT06659445 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration
NCT00447954 ·Status: COMPLETED ·Phase: PHASE2
-
NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration
NCT05984927 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD
NCT02461771 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes
NCT01846351 ·Status: COMPLETED
-
ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)
NCT03362190 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD
NCT04331730 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration
NCT01922128 ·Status: COMPLETED ·Phase: PHASE1
-
Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)
NCT01186432 ·Status: COMPLETED ·Phase: PHASE1
-
Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration
NCT01824225 ·Status: COMPLETED ·Phase: PHASE4
-
Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept
NCT03468296 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration
NCT02127463 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration
NCT00306488 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation and Treatment of Patients With Retinal Disease
NCT00005784 ·Status: COMPLETED
-
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT07215234 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the Faricimab Prefilled Syringe
NCT05569148 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I/II Safety, Tolerability, Immunogenicity, and Bioactivity Study of DE-122 Injectable Solution for Refractory Exudative Age-related Macular Degeneration
NCT02555306 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration
NCT01601483 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)
NCT05859776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
NCT05438732 ·Status: RECRUITING ·Phase: NA
-
Long-Term Efficacy in AMD of Rheopheresis in North America
NCT00380172 ·Status: UNKNOWN ·Phase: NA
-
A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa
NCT00447980 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59
NCT03144999 ·Status: COMPLETED ·Phase: PHASE1